Literature DB >> 32229744

CORR Insights®: Can Sural Fasciocutaneous Flaps Be Effective in Patients Older Than 65?

Amit Roshan1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32229744      PMCID： PMC7282600          DOI： 10.1097/CORR.0000000000001006

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  7 in total

1.  Delayed reverse sural flap for staged reconstruction of the foot and lower leg.

Authors:  Ulrich Kneser; Alexander D Bach; Elias Polykandriotis; Juergen Kopp; Raymund E Horch
Journal:  Plast Reconstr Surg       Date:  2005-12       Impact factor: 4.730

Review 2.  Vascular delay revisited.

Authors:  Shadi Ghali; Peter E M Butler; Oren M Tepper; Geoffrey C Gurtner
Journal:  Plast Reconstr Surg       Date:  2007-05       Impact factor: 4.730

3.  Comparison of Reverse Sural Artery Flap Healing for Traumatic Injuries Above and Below the Ankle Joint.

Authors:  Rajamani Perumal; Kaushik Bhowmick; Karuppusami Reka; Abel Livingston; P R J V C Boopalan; Thilak Samuel Jepegnanam
Journal:  J Foot Ankle Surg       Date:  2019-03       Impact factor: 1.286

4.  Sural flap delay procedure: a preliminary report.

Authors:  Detlev Erdmann; Neil Gottlieb; J Stewart Humphrey; Trung C Le; William Bruno; L Scott Levin
Journal:  Ann Plast Surg       Date:  2005-05       Impact factor: 1.539

5.  Distally based fasciocutaneous flap from the sural region. A preliminary report.

Authors:  P K Donski; I Fogdestam
Journal:  Scand J Plast Reconstr Surg       Date:  1983

6.  A realistic complication analysis of 70 sural artery flaps in a multimorbid patient group.

Authors:  Steffen P Baumeister; Roberto Spierer; Detlev Erdmann; Ranja Sweis; L Scott Levin; Guenter K Germann
Journal:  Plast Reconstr Surg       Date:  2003-07       Impact factor: 4.730

7.  Can Sural Fasciocutaneous Flaps Be Effective in Patients Older Than 65?

Authors:  Haydn J Roberts; Gregory L DeSilva
Journal:  Clin Orthop Relat Res       Date:  2020-04       Impact factor: 4.755
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.